Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Prognostic Value of Minimal Residual Disease before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Olga Pérez-López, MD, Teresa Caballero-Velázquez, MD PhD, Enrique Colado, MD PhD, Sara Alonso, MD, José González-Campos, MD, Concepción Prats-Martín, MD, Nancy Rodríguez-Torres, MD, Virginia Escamilla Gomez, Ildefonso Espigado, MD PhD, Jose Antonio Pérez-Simón

Blood (2018) 132 (Supplement 1): 5733.

https://doi.org/10.1182/blood-2018-99-119437

Published: 2018

Journal Articles

Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of a Multicenter Study from the Grupo Español De Trasplante Hematopoyético (GETH)

Blood (2018) 132 (Supplement 1): 200.

https://doi.org/10.1182/blood-2018-200

Published: 2018

Journal Articles

Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study

Blood (2017) 130 (Supplement 1): 1983.

https://doi.org/10.1182/blood.V130.Suppl_1.1983.1983

Published: 2017

Journal Articles

Description of Mutational Profile in Patients with Lower-Risk Myelodysplastic Syndromes at the Time of Leukemic Progression

Begoña Pedrote, Jose Francisco Falantes, Estrella Carrillo, Cristina Calderon-Cabrera, Francisco J Marquez-Malaver, Ildefonso Espigado, MD PhD, Jose A. Perez-Simon, MD PhD

Blood (2017) 130 (Supplement 1): 5301.

https://doi.org/10.1182/blood.V130.Suppl_1.5301.5301

Published: 2017

Journal Articles

Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm

Eduardo Rodríguez-Arbolí, MD, Francisco J. Márquez-Malaver, RN, Nancy Rodríguez-Torres, MD, Teresa Caballero-Velázquez, MD PhD, Virginia Escamilla Gomez, Cristina Calderón-Cabrera, MD, José F. Falantes, MD, Ildefonso Espigado, MD PhD, José A. Pérez-Simón

Blood (2017) 130 (Supplement 1): 5548.

https://doi.org/10.1182/blood.V130.Suppl_1.5548.5548

Published: 2017

Journal Articles

Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation

Sarmiento Mauricio, MDPhD, Ildefonso Espigado, MD PhD, Rocio Parody, MD, Francisco Marquez, NR, Jose Falantes, MD, Teresa Caballero, PhD, Cristina Calderon, MD, Magdalena Carmona, MDPhD, Jose Lopez, MDPhD, Jose A. Perez-Simon, MD, PhD

Blood (2015) 126 (23): 4363.

https://doi.org/10.1182/blood.V126.23.4363.4363

Published: 2015

Journal Articles

A New Multiple Single-Nucleotide Polymorphisms Based Predictive Model for Grades III to IV and Extensive Graft Versus Host Disease after Identical HLA-Allogeneic Stem-Cell

Blood (2015) 126 (23): 921.

https://doi.org/10.1182/blood.V126.23.921.921

Published: 2015

Journal Articles

Prognostic Impact of Adverse Karyotype and Treatment in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia

Virginia Escamilla, Resident Physician, Jose Falantes, MD, Cristina Calderon, MD, Jose Gonzalez Campos, MD, Rosario Morales Camacho, MD PhD, Isabel Montero, MD, Rocio Parody, MD PhD, Ricardo Bernal, MD PhD, Ildefonso Espigado, MD PhD, Jose A Perez-Simón, MD PhD

Blood (2015) 126 (23): 5241.

https://doi.org/10.1182/blood.V126.23.5241.5241

Published: 2015

Journal Articles

Donor Genotypes For Interleukin-17A Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation Of Complications After HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)

Blood (2013) 122 (21): 4619.

https://doi.org/10.1182/blood.V122.21.4619.4619

Published: 2013

Journal Articles

Multivariable Time-Dependent Analysis Of The Impact Of 5 Azacitidine In Patients With Lower-Risk Myelodysplastic Syndrome and Unfavorable Specific Lower-Risk Score

Blood (2013) 122 (21): 2754.

https://doi.org/10.1182/blood.V122.21.2754.2754

Published: 2013

Journal Articles

A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

Beatriz Martin-Antonio, Ph.D., Maria Suarez-LLedo, Montserrat Arroyes, Francesc Fernandez-Avilés, Carmen Martinez, MD, Montserrat Rovira, Ildefonso Espigado, MD, PhD, David Gallardo, MD, PhD, Anna Bosch, Ismael Buno, PhD, Carolina Martinez-Laperche, PhD, Antonio Jimenez-Velasco, Rafael De La Camara, MD, Salut Brunet, Jose B. Nieto, Alvaro Urbano-Ispizua, MD/Ph.D

Blood (2012) 120 (21): 468.

https://doi.org/10.1182/blood.V120.21.468.468

Published: 2012

Journal Articles

Increased Gene Expression Involved in Angiogenesis, Metabolism and Cell Proliferation in Acute Myeloid Leukemia and myelodysplastic Syndromes Correlates with Adverse Clinical and Biological Features

Jose F Falantes, MD, Pablo Trujillo, Cristina Calderón, MD, Jose Gonzalez, MD, Maria Luz Martino, Isabel Montero, MD, Rocio Parody, MD, Ildefonso Espigado, MD, PhD, Jose Antonio Perez-Simón

Blood (2012) 120 (21): 1457.

https://doi.org/10.1182/blood.V120.21.1457.1457

Published: 2012

Journal Articles

Patterns of Infection in Patients with Myeloid Malignancies Receiving 5-Azacytidine: identification of Candidates for Antifungal Prophylaxis

Cristina Calderón, MD, Jose F Falantes, MD, Francisco Márquez-Malaver, MD, Jose González, MD, PhD, Maria Luz Martino, MD, Isabel Montero, MD, Ildefonso Espigado, MD, PhD, Jose Antonio Pérez-Simón, MD, PhD

Blood (2012) 120 (21): 4955.

https://doi.org/10.1182/blood.V120.21.4955.4955

Published: 2012

Journal Articles

Prognostic Factors for Survival and Progression to Acute Myeloid Leukemia in Patients with Lower-Risk Myelodysplastic Syndromes. A New Scoring System

Jose F Falantes, MD, Cristina Calderón, MD, Ildefonso Espigado, MD, PhD, Dora Alonso, MD, Antonio Martín Noya, MD, PhD, Estrella Carrillo, MD, Maria Luz Martino, MD, Isabel Montero, MD, Jose González, MD, PhD, Jose Antonio Pérez-Simón, MD, PhD

Blood (2011) 118 (21): 1730.

https://doi.org/10.1182/blood.V118.21.1730.1730

Published: 2011

Journal Articles

Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT

Blood (2011) 118 (21): 3056.

https://doi.org/10.1182/blood.V118.21.3056.3056

Published: 2011

Journal Articles

Rituximab, Either As Single Agent or in Combination, Is Superior to Other Treatments in Terms of Response Rate and Progression-Free Survival (PFS) in Patients with Splenic Marginal Zone Lymphoma (SMZL)

Ana Marin-Niebla, MD, Monica Else, MA, MSc, Fatima De la Cruz, MD, Paul Batty, MD, Eduardo Rios-Herranz, MD, Claire E. Dearden, Ildefonso Espigado, MD, PhD, Jose Antonio Pérez Simón, MD, PhD, Daniel Catovsky, MD, Estella Matutes

Blood (2011) 118 (21): 4986.

https://doi.org/10.1182/blood.V118.21.4986.4986

Published: 2011

Journal Articles

-52G/A Gene Variant in the β-Defensin-1 ( DEBF1 ) Influences the Development of Severe Acute Graft Versus Host Disease (aGvHD) After Allogeneic Stem Cell Transplantation (Allo-SCT). Functional Association of This Variant with a Low Anti- Inflammatory Response

Beatriz Martin-Antonio, Damià Romero, David Gallardo, MD, PhD, Anna Bosch, Ildefonso Espigado, MD, PhD, Ismael Buno, Carolina Martinez-Laperche, Antonio Jimenez-Velasco, Rafael De La Camara, MD, Salut Brunet, Nieto B Jose, Jose Román, Maria Suarez-LLedo, Francesc Fernandez-Avilés, Carmen Martinez, Montserrat Rovira, Alvaro Urbano-Ispizua, MD

Blood (2011) 118 (21): 3052.

https://doi.org/10.1182/blood.V118.21.3052.3052

Published: 2011

Journal Articles

A Recessive Gene Variant in TGFB1 in the Donor Influences the Acute Graft Versus Host Disease Development and Impacts in the Outcome After Allogeneic Stem Cell Transplantation (Allo-SCT),

Beatriz Martin-Antonio, Damià Romero, Ildefonso Espigado, MD, PhD, David Gallardo, MD, PhD, Anna Bosch, Ismael Buno, Carolina Martinez-Laperche, Antonio Jimenz-Velasco, Rafael De La Camara, MD, Salut Brunet, Jose B Nieto, Jose Román, Maria Suarez-LLedo, Francesc Fernandez-Avilés, Carmen Martinez, MD, Montserrat Rovira, Alvaro Urbano-Ispizua, MD

Blood (2011) 118 (21): 4080.

https://doi.org/10.1182/blood.V118.21.4080.4080

Published: 2011

Journal Articles

The Genotype in the Donor and Recipient for the Polymorphim −174 G/C of the IL-6 Influences the Outcome of HLA-Identical Related Stem Cell Transplantation,

Blood (2011) 118 (21): 4082.

https://doi.org/10.1182/blood.V118.21.4082.4082

Published: 2011

Journal Articles

Intensification of Chemotherapeutic Regimens and Hematopoietic Stem Cell Transplantation Are Responsible for Improved Overall Survival in Adult Acute Lymphoblastic Leukemia in a Single Center Over the Last Forty Years

Estrella Carrillo, MD, Nancy Rodriguez, Juan Francisco Dominguez, Jose Gonzalez, MD, Jose Francisco Falantes, MD, Isabel Montero, MD, M. Luz Martino, MD, Francisco Márquez-Malaver, Ricardo Parody, MD, Estefania Garcia-Guerrero, Jose Antonio Perez-Simón, Sr., MD, PhD, Ildefonso Espigado, MD, PhD

Blood (2011) 118 (21): 4227.

https://doi.org/10.1182/blood.V118.21.4227.4227

Published: 2011

NARROW

Prognostic Value of Minimal Residual Disease before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of a Multicenter Study from the Grupo Español De Trasplante Hematopoyético (GETH)

Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study

Description of Mutational Profile in Patients with Lower-Risk Myelodysplastic Syndromes at the Time of Leukemic Progression

Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm

Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation

A New Multiple Single-Nucleotide Polymorphisms Based Predictive Model for Grades III to IV and Extensive Graft Versus Host Disease after Identical HLA-Allogeneic Stem-Cell

Prognostic Impact of Adverse Karyotype and Treatment in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia

Donor Genotypes For Interleukin-17A Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation Of Complications After HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)

Multivariable Time-Dependent Analysis Of The Impact Of 5 Azacitidine In Patients With Lower-Risk Myelodysplastic Syndrome and Unfavorable Specific Lower-Risk Score

A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

Increased Gene Expression Involved in Angiogenesis, Metabolism and Cell Proliferation in Acute Myeloid Leukemia and myelodysplastic Syndromes Correlates with Adverse Clinical and Biological Features

Patterns of Infection in Patients with Myeloid Malignancies Receiving 5-Azacytidine: identification of Candidates for Antifungal Prophylaxis

Prognostic Factors for Survival and Progression to Acute Myeloid Leukemia in Patients with Lower-Risk Myelodysplastic Syndromes. A New Scoring System

Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT

Rituximab, Either As Single Agent or in Combination, Is Superior to Other Treatments in Terms of Response Rate and Progression-Free Survival (PFS) in Patients with Splenic Marginal Zone Lymphoma (SMZL)

-52G/A Gene Variant in the β-Defensin-1 ( DEBF1 ) Influences the Development of Severe Acute Graft Versus Host Disease (aGvHD) After Allogeneic Stem Cell Transplantation (Allo-SCT). Functional Association of This Variant with a Low Anti- Inflammatory Response

A Recessive Gene Variant in TGFB1 in the Donor Influences the Acute Graft Versus Host Disease Development and Impacts in the Outcome After Allogeneic Stem Cell Transplantation (Allo-SCT),

The Genotype in the Donor and Recipient for the Polymorphim −174 G/C of the IL-6 Influences the Outcome of HLA-Identical Related Stem Cell Transplantation,

Intensification of Chemotherapeutic Regimens and Hematopoietic Stem Cell Transplantation Are Responsible for Improved Overall Survival in Adult Acute Lymphoblastic Leukemia in a Single Center Over the Last Forty Years

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only